Go Pro
→ The trade I’ve been waiting for since 2011 (From Traders Agency) (Ad)tc pixel Free CDIOW Stock Alerts

Cardio Diagnostics (CDIOW) Competitors

Cardio Diagnostics logo
$0.01 0.00 (-14.17%)
As of 01:30 PM Eastern
Compare

CDIOW vs. ALVOW, APLMW, ARAV, BIAFW, and BIVIW

Should you buy Cardio Diagnostics stock or one of its competitors? Cardio Diagnostics's main competitors and comparable companies include Alvotech (ALVOW), Apollomics (APLMW), Aravive (ARAV), bioAffinity Technologies (BIAFW), and BioVie (BIVIW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does Cardio Diagnostics compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and Cardio Diagnostics (NASDAQ:CDIOW) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, analyst recommendations, dividends, profitability, valuation, risk and earnings.

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
Cardio Diagnostics N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$491.95MN/AN/AN/AN/A
Cardio Diagnostics$14.45KN/AN/AN/AN/A

In the previous week, Alvotech had 2 more articles in the media than Cardio Diagnostics. MarketBeat recorded 3 mentions for Alvotech and 1 mentions for Cardio Diagnostics. Cardio Diagnostics' average media sentiment score of 1.89 beat Alvotech's score of 1.87 indicating that Cardio Diagnostics is being referred to more favorably in the news media.

Company Overall Sentiment
Alvotech Very Positive
Cardio Diagnostics Very Positive

Summary

Alvotech beats Cardio Diagnostics on 2 of the 3 factors compared between the two stocks.

How does Cardio Diagnostics compare to Apollomics?

Apollomics (NASDAQ:APLMW) and Cardio Diagnostics (NASDAQ:CDIOW) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, earnings, risk, valuation, institutional ownership, media sentiment, dividends and analyst recommendations.

Company Net Margins Return on Equity Return on Assets
ApollomicsN/A N/A N/A
Cardio Diagnostics N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apollomics$8.50MN/AN/AN/AN/A
Cardio Diagnostics$14.45KN/AN/AN/AN/A

In the previous week, Apollomics and Apollomics both had 1 articles in the media. Apollomics' average media sentiment score of 1.89 equaled Cardio Diagnostics'average media sentiment score.

Company Overall Sentiment
Apollomics Very Positive
Cardio Diagnostics Very Positive

Summary

Apollomics beats Cardio Diagnostics on 1 of the 1 factors compared between the two stocks.

How does Cardio Diagnostics compare to Aravive?

Aravive (NASDAQ:ARAV) and Cardio Diagnostics (NASDAQ:CDIOW) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, earnings, risk, valuation, institutional ownership, media sentiment, dividends and analyst recommendations.

In the previous week, Cardio Diagnostics had 1 more articles in the media than Aravive. MarketBeat recorded 1 mentions for Cardio Diagnostics and 0 mentions for Aravive. Cardio Diagnostics' average media sentiment score of 1.89 beat Aravive's score of 0.00 indicating that Cardio Diagnostics is being referred to more favorably in the news media.

Company Overall Sentiment
Aravive Neutral
Cardio Diagnostics Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AraviveN/AN/AN/A-$0.90N/A
Cardio Diagnostics$14.45KN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
AraviveN/A N/A N/A
Cardio Diagnostics N/A N/A N/A

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Cardio Diagnostics beats Aravive on 3 of the 5 factors compared between the two stocks.

How does Cardio Diagnostics compare to bioAffinity Technologies?

bioAffinity Technologies (NASDAQ:BIAFW) and Cardio Diagnostics (NASDAQ:CDIOW) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, institutional ownership, analyst recommendations, risk, earnings and profitability.

In the previous week, bioAffinity Technologies and bioAffinity Technologies both had 1 articles in the media. bioAffinity Technologies' average media sentiment score of 1.89 equaled Cardio Diagnostics'average media sentiment score.

Company Overall Sentiment
bioAffinity Technologies Very Positive
Cardio Diagnostics Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
bioAffinity Technologies$5.85MN/AN/AN/AN/A
Cardio Diagnostics$14.45KN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
bioAffinity TechnologiesN/A N/A N/A
Cardio Diagnostics N/A N/A N/A

Summary

bioAffinity Technologies beats Cardio Diagnostics on 1 of the 1 factors compared between the two stocks.

How does Cardio Diagnostics compare to BioVie?

BioVie (NASDAQ:BIVIW) and Cardio Diagnostics (NASDAQ:CDIOW) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, analyst recommendations, media sentiment, earnings, dividends and profitability.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioVieN/AN/AN/AN/AN/A
Cardio Diagnostics$14.45KN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
BioVieN/A N/A N/A
Cardio Diagnostics N/A N/A N/A

In the previous week, BioVie had 2 more articles in the media than Cardio Diagnostics. MarketBeat recorded 3 mentions for BioVie and 1 mentions for Cardio Diagnostics. Cardio Diagnostics' average media sentiment score of 1.89 beat BioVie's score of 0.63 indicating that Cardio Diagnostics is being referred to more favorably in the news media.

Company Overall Sentiment
BioVie Positive
Cardio Diagnostics Very Positive

Summary

Cardio Diagnostics beats BioVie on 2 of the 3 factors compared between the two stocks.

Get Cardio Diagnostics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CDIOW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CDIOW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CDIOW vs. The Competition

Export
MetricCardio DiagnosticsBiotechnology IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$3.85B$7.22B$14.96B
Dividend YieldN/A3.65%2.57%11.71%
P/E RatioN/A14.53273.8825.47
Price / SalesN/A1,418.90698.66113.02
Price / CashN/A108.9477.7151.48
Price / BookN/A15.1910.396.24
Net IncomeN/A-$22.78M$3.49B$358.32M
7 Day PerformanceN/A-3.45%-1.31%-1.11%
1 Month PerformanceN/A-2.01%-1.01%-4.11%
1 Year PerformanceN/A38.19%18.75%6.24%

Cardio Diagnostics Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CDIOW
Cardio Diagnostics
N/A$0.01
-14.2%		N/A-38.8%$0.00$14.45KN/A7
ALVOW
Alvotech
N/A$0.33
flat		N/A-71.0%$0.00$491.95MN/A4
APLMW
Apollomics
N/A$0.01
flat		N/A-35.8%$0.00$8.50MN/A59
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00N/AN/A20
BIAFW
bioAffinity Technologies
N/A$0.13
-33.8%		N/A+34.4%$0.00$5.85MN/A10

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:CDIOW) was last updated on 9/16/2026 by MarketBeat.com Staff.
From Our Partners
America Relied on Its Biggest Rival for This Military Metal
Antimony strengthens ammunition, missiles, sensors, batteries and semiconductors, yet the US ceded most produc...
i2i Marketing Group, LLC | Sponsoredtc pixel
$40,000,000,000,000
The national debt just hit 40 trillion dollars, and the U.S. now spends more on interest payments than on its ...
American Alternative | Sponsoredtc pixel
Why major institutions are piling into this digital asset now
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely | Sponsoredtc pixel
DOJ Admits It In Court—Your Cash Can Be Seized Without Warning
The Department of Justice recently argued in court that cash may not be legally your property - raising concer...
Priority Gold | Sponsoredtc pixel
The national debt just passed $39 trillion
The U.S. national debt just topped $39 trillion, up nearly $3 trillion in a single year and on pace to hit $40...
US Gold Bureau | Sponsoredtc pixel
“This is the Perfect Tech Stock”
Jeff Brown, the tech investor who identified Nvidia in 2016 before its 37,000% run, has flagged a new AI compa...
Brownstone Research | Sponsoredtc pixel
Is This the New Normal for Gold?
Barrick Mining has spent decades building one of the world's great gold districts in Nevada, anchored by Fourm...
Wall Street Logic | Sponsoredtc pixel
The Flaw Your Financial Advisor Will Not Name
The U.S. government values its gold at $42 an ounce, a price set by Congress in 1973 and never updated. Gold t...
Monetary Gold | Sponsoredtc pixel